Compile Data Set for Download or QSAR
Report error Found 260 Enz. Inhib. hit(s) with all data for entry = 223
TargetProstaglandin D2 receptor 2(Human)
Array Biopharma

US Patent
LigandPNGBDBM231198(US9556139, 106 Enantiomer 2 106)
Affinity DataEC50:  2.65nMpH: 7.4 T: 2°CAssay Description:The coding sequence of human DP2 was introduced into the human Leukemic cell line K562 by electroporation and stable clones expressing DP2 were obtai...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2018
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Array Biopharma

US Patent
LigandPNGBDBM231191(Sodium 6-chloro-7-(4-(4-chloro-2-methoxyphenethylc...)
Affinity DataEC50:  5.10nMpH: 7.4 T: 2°CAssay Description:The coding sequence of human DP2 was introduced into the human Leukemic cell line K562 by electroporation and stable clones expressing DP2 were obtai...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2018
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Array Biopharma

US Patent
LigandPNGBDBM231168(6-Cyano-7-(4-(naphthalen-2-ylcarbamoyl)phenoxy)chr...)
Affinity DataEC50:  6.70nMpH: 7.4 T: 2°CAssay Description:The coding sequence of human DP2 was introduced into the human Leukemic cell line K562 by electroporation and stable clones expressing DP2 were obtai...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2018
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Array Biopharma

US Patent
LigandPNGBDBM231194(Sodium 6-chloro-7-(4-(2-methoxy-4-(trifluoromethyl...)
Affinity DataEC50:  7.70nMpH: 7.4 T: 2°CAssay Description:The coding sequence of human DP2 was introduced into the human Leukemic cell line K562 by electroporation and stable clones expressing DP2 were obtai...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2018
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Array Biopharma

US Patent
LigandPNGBDBM230043(US9556139, 11 Enantiomer 2)
Affinity DataEC50:  9.30nMpH: 7.4 T: 2°CAssay Description:The coding sequence of human DP2 was introduced into the human Leukemic cell line K562 by electroporation and stable clones expressing DP2 were obtai...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2018
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Array Biopharma

US Patent
LigandPNGBDBM230066(Sodium 6-chloro-7-(4-(4-chloro-2-cyclopropylphenet...)
Affinity DataEC50:  10.5nMpH: 7.4 T: 2°CAssay Description:The coding sequence of human DP2 was introduced into the human Leukemic cell line K562 by electroporation and stable clones expressing DP2 were obtai...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2018
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Array Biopharma

US Patent
LigandPNGBDBM228438(Ethyl 6-chloro-7-hydroxychroman-4-carboxylate | US...)
Affinity DataEC50:  10.7nMpH: 7.4 T: 2°CAssay Description:The coding sequence of human DP2 was introduced into the human Leukemic cell line K562 by electroporation and stable clones expressing DP2 were obtai...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2018
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Array Biopharma

US Patent
LigandPNGBDBM230543(7-(4-((4-(Trifluoromethyl)phenethyl)carbamoyl)phen...)
Affinity DataEC50:  11nMpH: 7.4 T: 2°CAssay Description:The coding sequence of human DP2 was introduced into the human Leukemic cell line K562 by electroporation and stable clones expressing DP2 were obtai...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2018
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Array Biopharma

US Patent
LigandPNGBDBM234930(6-Chloro-7-(4-(4-chloro-2-hydroxyphenethylcarbamoy...)
Affinity DataEC50:  11.1nMpH: 7.4 T: 2°CAssay Description:The coding sequence of human DP2 was introduced into the human Leukemic cell line K562 by electroporation and stable clones expressing DP2 were obtai...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2018
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Array Biopharma

US Patent
LigandPNGBDBM231155(6-Cyano-7-(4-(4-(trifluoromethyl)phenylcarbamoyl)p...)
Affinity DataEC50:  11.9nMpH: 7.4 T: 2°CAssay Description:The coding sequence of human DP2 was introduced into the human Leukemic cell line K562 by electroporation and stable clones expressing DP2 were obtai...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2018
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Array Biopharma

US Patent
LigandPNGBDBM230069(Sodium 6-chloro-7-(4-(2,4-dichloro-6-methoxyphenet...)
Affinity DataEC50:  12nMpH: 7.4 T: 2°CAssay Description:The coding sequence of human DP2 was introduced into the human Leukemic cell line K562 by electroporation and stable clones expressing DP2 were obtai...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2018
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Array Biopharma

US Patent
LigandPNGBDBM230079(7-(4-((2-Phenylcyclopropyl)carbamoyl)phenoxy)-6-cy...)
Affinity DataEC50:  12.1nMpH: 7.4 T: 2°CAssay Description:The coding sequence of human DP2 was introduced into the human Leukemic cell line K562 by electroporation and stable clones expressing DP2 were obtai...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2018
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Array Biopharma

US Patent
LigandPNGBDBM230643(6-Cyano-7-(4-(2-(naphthalen-1-yl)ethylcarbamoyl)ph...)
Affinity DataEC50:  12.1nMpH: 7.4 T: 2°CAssay Description:The coding sequence of human DP2 was introduced into the human Leukemic cell line K562 by electroporation and stable clones expressing DP2 were obtai...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2018
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Array Biopharma

US Patent
LigandPNGBDBM230608(7-(4-((2-(4-Chlorophenyl)cyclopropyl)carbamoyl)phe...)
Affinity DataEC50:  12.1nMpH: 7.4 T: 2°CAssay Description:The coding sequence of human DP2 was introduced into the human Leukemic cell line K562 by electroporation and stable clones expressing DP2 were obtai...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2018
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Array Biopharma

US Patent
LigandPNGBDBM230042(6-Chloro-7-(4-(4-chlorophenethylcarbamoyl)phenoxy)...)
Affinity DataEC50:  13.9nMpH: 7.4 T: 2°CAssay Description:The coding sequence of human DP2 was introduced into the human Leukemic cell line K562 by electroporation and stable clones expressing DP2 were obtai...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2018
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Array Biopharma

US Patent
LigandPNGBDBM230644(6-Cyano-7-(4-(2-(naphthalen-2-yl)ethylcarbamoyl)ph...)
Affinity DataEC50:  14.2nMpH: 7.4 T: 2°CAssay Description:The coding sequence of human DP2 was introduced into the human Leukemic cell line K562 by electroporation and stable clones expressing DP2 were obtai...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2018
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Array Biopharma

US Patent
LigandPNGBDBM230608(7-(4-((2-(4-Chlorophenyl)cyclopropyl)carbamoyl)phe...)
Affinity DataEC50:  14.8nMpH: 7.4 T: 2°CAssay Description:The coding sequence of human DP2 was introduced into the human Leukemic cell line K562 by electroporation and stable clones expressing DP2 were obtai...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2018
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Array Biopharma

US Patent
LigandPNGBDBM230078(Sodium 6,8-dichloro-7-(4-(4-chlorophenethylcarbamo...)
Affinity DataEC50:  15.8nMpH: 7.4 T: 2°CAssay Description:The coding sequence of human DP2 was introduced into the human Leukemic cell line K562 by electroporation and stable clones expressing DP2 were obtai...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2018
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Array Biopharma

US Patent
LigandPNGBDBM230040(2-(4-Chloro-2-methoxyphenyl)ethanamine | US9556139...)
Affinity DataEC50:  16nMpH: 7.4 T: 2°CAssay Description:The coding sequence of human DP2 was introduced into the human Leukemic cell line K562 by electroporation and stable clones expressing DP2 were obtai...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2018
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Array Biopharma

US Patent
LigandPNGBDBM234939(US9556139, 238 Enantiomer 2)
Affinity DataEC50:  16.2nMpH: 7.4 T: 2°CAssay Description:The coding sequence of human DP2 was introduced into the human Leukemic cell line K562 by electroporation and stable clones expressing DP2 were obtai...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2018
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Array Biopharma

US Patent
LigandPNGBDBM232977(Sodium 6-chloro-7-(4-(2,4-dimethoxyphenethylcarbam...)
Affinity DataEC50:  16.4nMpH: 7.4 T: 2°CAssay Description:The coding sequence of human DP2 was introduced into the human Leukemic cell line K562 by electroporation and stable clones expressing DP2 were obtai...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2018
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Array Biopharma

US Patent
LigandPNGBDBM228392(6-Cyano-7-(4-(4-chlorophenylcarbamoyl)phenoxy)chro...)
Affinity DataEC50:  16.6nMpH: 7.4 T: 2°CAssay Description:The coding sequence of human DP2 was introduced into the human Leukemic cell line K562 by electroporation and stable clones expressing DP2 were obtai...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2018
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Array Biopharma

US Patent
LigandPNGBDBM234933(US9556139, 235 Enantiomer 2)
Affinity DataEC50:  17nMpH: 7.4 T: 2°CAssay Description:The coding sequence of human DP2 was introduced into the human Leukemic cell line K562 by electroporation and stable clones expressing DP2 were obtai...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2018
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Array Biopharma

US Patent
LigandPNGBDBM230068(Sodium 6-chloro-7-(4-(4-cyclopropyl-2-methoxyphene...)
Affinity DataEC50:  17.3nMpH: 7.4 T: 2°CAssay Description:The coding sequence of human DP2 was introduced into the human Leukemic cell line K562 by electroporation and stable clones expressing DP2 were obtai...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2018
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Array Biopharma

US Patent
LigandPNGBDBM230645(7-(4-(4-tert-Butylphenethylcarbamoyl)phenoxy)-6-cy...)
Affinity DataEC50:  18.9nMpH: 7.4 T: 2°CAssay Description:The coding sequence of human DP2 was introduced into the human Leukemic cell line K562 by electroporation and stable clones expressing DP2 were obtai...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2018
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Array Biopharma

US Patent
LigandPNGBDBM230039(US9556139, 7)
Affinity DataEC50:  19nMpH: 7.4 T: 2°CAssay Description:The coding sequence of human DP2 was introduced into the human Leukemic cell line K562 by electroporation and stable clones expressing DP2 were obtai...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2018
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Array Biopharma

US Patent
LigandPNGBDBM234931(US9556139, 234 Enantiomer 2)
Affinity DataEC50:  21.7nMpH: 7.4 T: 2°CAssay Description:The coding sequence of human DP2 was introduced into the human Leukemic cell line K562 by electroporation and stable clones expressing DP2 were obtai...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2018
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Array Biopharma

US Patent
LigandPNGBDBM231253(7-(4-(4-Chlorophenethylcarbamoyl)-2-methylphenoxy)...)
Affinity DataEC50:  21.9nMpH: 7.4 T: 2°CAssay Description:The coding sequence of human DP2 was introduced into the human Leukemic cell line K562 by electroporation and stable clones expressing DP2 were obtai...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2018
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Array Biopharma

US Patent
LigandPNGBDBM230498(7-(4-((4-Fluorophenethyl)carbamoyl)phenoxy)-6-cyan...)
Affinity DataEC50:  22.5nMpH: 7.4 T: 2°CAssay Description:The coding sequence of human DP2 was introduced into the human Leukemic cell line K562 by electroporation and stable clones expressing DP2 were obtai...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2018
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Array Biopharma

US Patent
LigandPNGBDBM231153(7-(4-(4-Chlorophenylcarbamoyl)phenoxy)-6-cyanochro...)
Affinity DataEC50:  23.3nMpH: 7.4 T: 2°CAssay Description:The coding sequence of human DP2 was introduced into the human Leukemic cell line K562 by electroporation and stable clones expressing DP2 were obtai...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2018
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Array Biopharma

US Patent
LigandPNGBDBM234937(US9556139, 237 Enantiomer 2)
Affinity DataEC50:  25.6nMpH: 7.4 T: 2°CAssay Description:The coding sequence of human DP2 was introduced into the human Leukemic cell line K562 by electroporation and stable clones expressing DP2 were obtai...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2018
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Array Biopharma

US Patent
LigandPNGBDBM231500(6-Cyano-7-(4-((R)-2-phenylpropylcarbamoyl)phenoxy)...)
Affinity DataEC50:  25.7nMpH: 7.4 T: 2°CAssay Description:The coding sequence of human DP2 was introduced into the human Leukemic cell line K562 by electroporation and stable clones expressing DP2 were obtai...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2018
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Array Biopharma

US Patent
LigandPNGBDBM234904(sodium 6-chloro-7-(4-(4-chloro-2- phenoxyphen-ethy...)
Affinity DataEC50:  26.4nMpH: 7.4 T: 2°CAssay Description:The coding sequence of human DP2 was introduced into the human Leukemic cell line K562 by electroporation and stable clones expressing DP2 were obtai...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2018
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Array Biopharma

US Patent
LigandPNGBDBM230080(7-(4-((3-Methoxyphenethyl)carbamoyl)phenoxy)-6-cya...)
Affinity DataEC50:  30.7nMpH: 7.4 T: 2°CAssay Description:The coding sequence of human DP2 was introduced into the human Leukemic cell line K562 by electroporation and stable clones expressing DP2 were obtai...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2018
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Array Biopharma

US Patent
LigandPNGBDBM234935(US9556139, 236 Enantiomer 2)
Affinity DataEC50:  34nMpH: 7.4 T: 2°CAssay Description:The coding sequence of human DP2 was introduced into the human Leukemic cell line K562 by electroporation and stable clones expressing DP2 were obtai...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2018
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Array Biopharma

US Patent
LigandPNGBDBM231147(6-Cyano-7-(4-(1,2,3,4-tetrahydronaphthalen-2-ylcar...)
Affinity DataEC50:  36.4nMpH: 7.4 T: 2°CAssay Description:The coding sequence of human DP2 was introduced into the human Leukemic cell line K562 by electroporation and stable clones expressing DP2 were obtai...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2018
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Array Biopharma

US Patent
LigandPNGBDBM234908(sodium 6-chloro-7-(4-(4-chloro- 2-(3-chlorophenoxy...)
Affinity DataEC50:  37.2nMpH: 7.4 T: 2°CAssay Description:The coding sequence of human DP2 was introduced into the human Leukemic cell line K562 by electroporation and stable clones expressing DP2 were obtai...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2018
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Array Biopharma

US Patent
LigandPNGBDBM230037(6-Cyano-7-(4-(phenethylcarbamoyl)phenoxy)chroman-4...)
Affinity DataEC50:  37.4nMpH: 7.4 T: 2°CAssay Description:The coding sequence of human DP2 was introduced into the human Leukemic cell line K562 by electroporation and stable clones expressing DP2 were obtai...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2018
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Array Biopharma

US Patent
LigandPNGBDBM231643(7-(4-(1-(4-Chlorophenyl)propan-2-ylcarbamoyl)pheno...)
Affinity DataEC50:  37.4nMpH: 7.4 T: 2°CAssay Description:The coding sequence of human DP2 was introduced into the human Leukemic cell line K562 by electroporation and stable clones expressing DP2 were obtai...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2018
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Array Biopharma

US Patent
LigandPNGBDBM231188(Sodium 6-chloro-7-(4-(2-(2′-chlorobiphenyl-2...)
Affinity DataEC50:  40.2nMpH: 7.4 T: 2°CAssay Description:The coding sequence of human DP2 was introduced into the human Leukemic cell line K562 by electroporation and stable clones expressing DP2 were obtai...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2018
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Array Biopharma

US Patent
LigandPNGBDBM234905(sodium 6-chloro-7-(4-(4-chloro-2- (4-chlorophenoxy...)
Affinity DataEC50:  41.4nMpH: 7.4 T: 2°CAssay Description:The coding sequence of human DP2 was introduced into the human Leukemic cell line K562 by electroporation and stable clones expressing DP2 were obtai...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2018
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Array Biopharma

US Patent
LigandPNGBDBM230072(Sodium 6,8-dicyclopropyl-7-(4-(2,4-dichloropheneth...)
Affinity DataEC50:  42.2nMpH: 7.4 T: 2°CAssay Description:The coding sequence of human DP2 was introduced into the human Leukemic cell line K562 by electroporation and stable clones expressing DP2 were obtai...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2018
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Array Biopharma

US Patent
LigandPNGBDBM231151(7-(4-(5-Chloro-2,3-dihydro-1H-inden-2-ylcarbamoyl)...)
Affinity DataEC50:  42.4nMpH: 7.4 T: 2°CAssay Description:The coding sequence of human DP2 was introduced into the human Leukemic cell line K562 by electroporation and stable clones expressing DP2 were obtai...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2018
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Array Biopharma

US Patent
LigandPNGBDBM234918(7-(4-(2,4-bis(trifluoromethyl) phenethylcarbamoyl)...)
Affinity DataEC50:  45nMpH: 7.4 T: 2°CAssay Description:The coding sequence of human DP2 was introduced into the human Leukemic cell line K562 by electroporation and stable clones expressing DP2 were obtai...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2018
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Array Biopharma

US Patent
LigandPNGBDBM234910(sodium 6-chloro-7-(4-(2-(2,4- dichlorophenoxy)-5- ...)
Affinity DataEC50:  45.1nMpH: 7.4 T: 2°CAssay Description:The coding sequence of human DP2 was introduced into the human Leukemic cell line K562 by electroporation and stable clones expressing DP2 were obtai...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2018
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Array Biopharma

US Patent
LigandPNGBDBM234929(6-chloro-7-(4-(2-cyclopropyl-4- (trifluoromethyl) ...)
Affinity DataEC50:  46.5nMpH: 7.4 T: 2°CAssay Description:The coding sequence of human DP2 was introduced into the human Leukemic cell line K562 by electroporation and stable clones expressing DP2 were obtai...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2018
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Array Biopharma

US Patent
LigandPNGBDBM234940(US9556139, 239 Enantiomer 2)
Affinity DataEC50:  48.1nMpH: 7.4 T: 2°CAssay Description:The coding sequence of human DP2 was introduced into the human Leukemic cell line K562 by electroporation and stable clones expressing DP2 were obtai...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2018
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Array Biopharma

US Patent
LigandPNGBDBM231194(Sodium 6-chloro-7-(4-(2-methoxy-4-(trifluoromethyl...)
Affinity DataEC50:  48.9nMpH: 7.4 T: 2°CAssay Description:The coding sequence of human DP2 was introduced into the human Leukemic cell line K562 by electroporation and stable clones expressing DP2 were obtai...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2018
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Array Biopharma

US Patent
LigandPNGBDBM231191(Sodium 6-chloro-7-(4-(4-chloro-2-methoxyphenethylc...)
Affinity DataEC50:  50.7nMpH: 7.4 T: 2°CAssay Description:The coding sequence of human DP2 was introduced into the human Leukemic cell line K562 by electroporation and stable clones expressing DP2 were obtai...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2018
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Array Biopharma

US Patent
LigandPNGBDBM230075(Sodium 6-chloro-8-cyclopropyl-7-(4-(2,4-dichloroph...)
Affinity DataEC50:  51.5nMpH: 7.4 T: 2°CAssay Description:The coding sequence of human DP2 was introduced into the human Leukemic cell line K562 by electroporation and stable clones expressing DP2 were obtai...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2018
Entry Details
US Patent

Displayed 1 to 50 (of 260 total ) | Next | Last >>
Jump to: